Ind-Swift Laboratories Limited (INDSWFTLAB.BO)
INR 83.56
(1.27%)
INR 83.56
(1.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 104.57 Million INR | -97.62% |
| 2022 | 4.38 Billion INR | 2.36% |
| 2021 | 4.28 Billion INR | 14.06% |
| 2020 | 3.75 Billion INR | 9.58% |
| 2019 | 3.42 Billion INR | 8.28% |
| 2018 | 3.16 Billion INR | 2.12% |
| 2017 | 3.1 Billion INR | -9.75% |
| 2016 | 3.43 Billion INR | -3.5% |
| 2015 | 3.56 Billion INR | 2.21% |
| 2014 | 3.48 Billion INR | -7.62% |
| 2013 | 3.77 Billion INR | -16.48% |
| 2012 | 4.51 Billion INR | -8.58% |
| 2011 | 4.93 Billion INR | 35.09% |
| 2010 | 3.65 Billion INR | 54.01% |
| 2009 | 2.37 Billion INR | 15.63% |
| 2008 | 2.05 Billion INR | 81.49% |
| 2007 | 1.13 Billion INR | 29.33% |
| 2006 | 874.6 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 104.57 Million INR | 0.0% |
| 2023 Q2 | 4.41 Billion INR | 0.0% |
| 2023 FY | 104.57 Million INR | -97.62% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 4.38 Billion INR | 2.36% |
| 2022 Q4 | 4.38 Billion INR | 0.0% |
| 2022 Q2 | 4.53 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 4.28 Billion INR | 14.06% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 3.96 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 4.28 Billion INR | 0.0% |
| 2020 Q4 | 3.75 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 3.75 Billion INR | 9.58% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 3.39 Billion INR | 0.0% |
| 2019 Q4 | 3.42 Billion INR | 0.0% |
| 2019 Q2 | 3.18 Billion INR | 0.0% |
| 2019 FY | 3.42 Billion INR | 8.28% |
| 2019 Q3 | - INR | -100.0% |
| 2018 FY | 3.16 Billion INR | 2.12% |
| 2018 Q4 | 3.16 Billion INR | 0.0% |
| 2017 FY | 3.1 Billion INR | -9.75% |
| 2016 FY | 3.43 Billion INR | -3.5% |
| 2015 FY | 3.56 Billion INR | 2.21% |
| 2014 FY | 3.48 Billion INR | -7.62% |
| 2013 FY | 3.77 Billion INR | -16.48% |
| 2012 Q4 | 4.51 Billion INR | 0.0% |
| 2012 FY | 4.51 Billion INR | -8.58% |
| 2012 Q2 | 8.77 Billion INR | 0.0% |
| 2011 FY | 4.93 Billion INR | 35.09% |
| 2010 FY | 3.65 Billion INR | 54.01% |
| 2009 FY | 2.37 Billion INR | 15.63% |
| 2008 FY | 2.05 Billion INR | 81.49% |
| 2007 FY | 1.13 Billion INR | 29.33% |
| 2006 FY | 874.6 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.894% |
| NATCO Pharma Limited | 7 Billion INR | 98.507% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 95.477% |
| Syncom Formulations (India) Limited | 210.81 Million INR | 50.394% |
| Achyut Healthcare Limited | 568 Thousand INR | -18311.444% |
| Ajanta Pharma Limited | 8.28 Billion INR | 98.738% |
| Alkem Laboratories Limited | 26.61 Billion INR | 99.607% |
| Alpa Laboratories Limited | 136.65 Million INR | 23.473% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.364% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 95.411% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.893% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 92.74% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 91.171% |
| Brooks Laboratories Limited | 96.1 Million INR | -8.812% |
| Divi's Laboratories Limited | 31.84 Billion INR | 99.672% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.835% |
| Eris Lifesciences Limited | 1.89 Billion INR | 94.468% |
| FDC Limited | 3.88 Billion INR | 97.311% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.584% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 98.431% |
| Granules India Limited | 13 Billion INR | 99.196% |
| Gufic Biosciences Limited | 2 Billion INR | 94.784% |
| Hester Biosciences Limited | 755.81 Million INR | 86.164% |
| Indoco Remedies Limited | 3.53 Billion INR | 97.038% |
| Ipca Laboratories Limited | 24.71 Billion INR | 99.577% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 30.268% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -6.75% |
| Lasa Supergenerics Limited | 190.43 Million INR | 45.085% |
| Laurus Labs Limited | 18.45 Billion INR | 99.433% |
| Lupin Limited | 49.53 Billion INR | 99.789% |
| Mankind Pharma Limited | 15.53 Billion INR | 99.327% |
| Medicamen Biotech Limited | 593.75 Million INR | 82.387% |
| Medico Remedies Limited | 163.37 Million INR | 35.988% |
| Megasoft Limited | - INR | -Infinity% |
| Piramal Pharma Limited | 21.75 Billion INR | 99.519% |
| RPG Life Sciences Limited | 1.01 Billion INR | 89.646% |
| Sigachi Industries Limited | 707.2 Million INR | 85.213% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | 7.04 Billion INR | 98.516% |
| Wanbury Limited | 360.23 Million INR | 70.97% |
| Windlas Biotech Limited | 621.89 Million INR | 83.184% |
| ZIM Laboratories Limited | 812.62 Million INR | 87.131% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 99.696% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 90.415% |
| Amrutanjan Health Care Limited | 289.04 Million INR | 63.82% |
| Bal Pharma Limited | 878.11 Million INR | 88.091% |
| Strides Pharma Science Limited | 11.26 Billion INR | 99.071% |
| Venus Remedies Limited | 1.21 Billion INR | 91.406% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 98.373% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 98.525% |
| Shilpa Medicare Limited | 3.44 Billion INR | 96.968% |
| Aarti Drugs Limited | 4.85 Billion INR | 97.848% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 97.538% |
| Suven Life Sciences Limited | 7.08 Million INR | -1376.034% |
| Ind-Swift Limited | 640.91 Million INR | 83.683% |
| Valiant Laboratories Limited | 100.15 Million INR | -4.416% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 97.919% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 97.093% |
| Themis Medicare Limited | 705.74 Million INR | 85.182% |
| Hikal Limited | 3.03 Billion INR | 96.557% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.541% |
| Sequent Scientific Limited | 3.46 Billion INR | 96.98% |
| Novartis India Limited | 448.6 Million INR | 76.688% |
| Wockhardt Limited | 6.4 Billion INR | 98.366% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 99.189% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -310.154% |
| Neuland Laboratories Limited | 3.5 Billion INR | 97.016% |
| Morepen Laboratories Limited | 2.48 Billion INR | 95.793% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -162.229% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 91.542% |